Authors:
LASNE D
KRENN M
PINGAULT V
ARNAUD E
FIESSINGER JN
AIACH M
RENDU F
Citation: D. Lasne et al., INTERDONOR VARIABILITY OF PLATELET RESPONSE TO THROMBIN RECEPTOR ACTIVATION - INFLUENCE OF PL(A2) POLYMORPHISM, British Journal of Haematology, 99(4), 1997, pp. 801-807
Authors:
LASNE D
SAFFROY R
BACHELOT C
VINCENOT A
RENDU F
PAPO T
AIACH M
PIETTE JC
Citation: D. Lasne et al., TESTS FOR HEPARIN-INDUCED THROMBOCYTOPENIA IN PRIMARY ANTIPHOSPHOLIPID SYNDROME, British Journal of Haematology, 97(4), 1997, pp. 939-939
Authors:
ALHENCGELAS M
LECAMDUCHEZ V
EMMERICH J
FREBOURG T
FIESSINGER JN
BORG JY
AIACH M
Citation: M. Alhencgelas et al., THE A20210-ALLELE OF THE PROTHROMBIN GENE IS NOT FREQUENTLY ASSOCIATED WITH THE FACTOR-V-ARG-506-TO-GLN-MUTATION IN THROMBOPHILIC FAMILIES, Blood, 90(4), 1997, pp. 1711-1711
Citation: K. Schwartz et M. Aiach, CARDIOVASCULAR SCIENCE IN FRANCE - FOCUS ON FAMILIAL CARDIOMYOPATHIESAND THROMBOPHILIA, Trends in cardiovascular medicine, 6(7), 1996, pp. 207-210
Authors:
BAUTERS A
ZAWADZKI C
BURA A
THERY C
WATEL A
SUBTIL D
AIACH M
EMMERICH J
JUDE B
Citation: A. Bauters et al., HOMOZYGOUS VARIANT OF ANTITHROMBIN WITH LACK OF AFFINITY FOR HEPARIN - MANAGEMENT OF SEVERE THROMBOTIC COMPLICATIONS ASSOCIATED WITH INTRAUTERINE FETAL DEMISE, Blood coagulation & fibrinolysis, 7(7), 1996, pp. 705-710
Authors:
SALEUN S
DEMOERLOOSE P
BURA A
AIACH M
EMMERICH J
Citation: S. Saleun et al., A NOVEL NONSENSE MUTATION IN THE ANTITHROMBIN-III GENE (CYS-4-]STOP) CAUSING RECURRENT VENOUS THROMBOSIS, Blood coagulation & fibrinolysis, 7(5), 1996, pp. 578-579
Authors:
EMMERICH J
ALHENCGELAS M
AIACH M
FIESSINGER JN
Citation: J. Emmerich et al., RESISTANCE TO ACTIVATED PROTEIN-C - ROLE IN VENOUS AND ARTERIAL THROMBOSIS, Biomedicine & pharmacotherapy, 50(6-7), 1996, pp. 254-260
Citation: D. Borgel et al., FIRST CASE OF SPORADIC PROTEIN-S DEFICIENCY DUE TO A NOVEL CANDIDATE MUTATION, ALA484-]PRO, IN THE PROTEIN-S ACTIVE GENE (PROS1), Thrombosis and haemostasis, 75(6), 1996, pp. 883-886
Authors:
ALHENCGELAS M
AILLAUD MF
BONVARLET MN
DUPUY G
JUHANVAGUE I
AIACH M
Citation: M. Alhencgelas et al., SPECIFICITY OF AN ASSAY BASED AN A FACTOR V-DEPLETED PLASMA IN PATIENTS CARRYING THE ARG-506 GLN MUTATION, Thrombosis and haemostasis, 75(6), 1996, pp. 976-977
Authors:
ESCOFFREBARBE M
ALHENCGELAS M
AIACH M
EMMERICH J
Citation: M. Escoffrebarbe et al., ABSENCE OF LENGTH POLYMORPHISM WITHIN THE 31 TANDEM REPEATS OF THE B-DOMAIN OF FACTOR-V, Thrombosis and haemostasis, 75(5), 1996, pp. 862-863
Authors:
DUCHEMIN J
BORG JY
BORGEL D
VASSE M
LEVEQUE H
AIACH M
GANDRILLE S
Citation: J. Duchemin et al., 5 NOVEL MUTATIONS OF THE PROTEIN-S ACTIVE GENE (PROS-1) IN 8 NORMAN FAMILIES, Thrombosis and haemostasis, 75(3), 1996, pp. 437-444
Authors:
BIOUSSE V
FRANCES C
PIETTE JC
TOURNIERLASSERVE E
AIACH M
Citation: V. Biousse et al., ACTIVATED PROTEIN-C RESISTANCE CAUSED BY FACTOR-V ARG-506-]GLN MUTATION IN 14 PATIENTS WITH SNEDDONS-SYNDROME, Neurology, 46(2), 1996, pp. 69003-69003
Authors:
BORGEL D
DUCHEMIN J
ALHENCGELAS M
MATHERON C
AIACH M
GANDRILLE S
Citation: D. Borgel et al., MOLECULAR-BASIS FOR PROTEIN-S HEREDITARY-DEFICIENCY - GENETIC-DEFECTSOBSERVED IN 118 PATIENTS WITH TYPE-I AND TYPE IIA DEFICIENCIES, The Journal of laboratory and clinical medicine, 128(2), 1996, pp. 218-227
Authors:
TRILLOT N
PREUDHOMME C
ALHENCGELAS M
GAVERIAUX V
BAUTERS A
GANDRILLE S
AIACH M
JUDE B
Citation: N. Trillot et al., THERMOLABILE METHYLENE TETRA HYDRO FOLATE REDUCTASE (MTHFR) DOES NOT MODIFY THE RISK FOR VENOUS THROMBOEMBOLISM IN SUBJECTS WITH HETEROZYGOUS FACTOR-V LEIDEN, Blood, 88(10), 1996, pp. 1126-1126
Citation: M. Aiach, HIRUDIN - THE RELATIVE FAILURE OF A VERY PROMISING MOLECULE, Archives des maladies du coeur et des vaisseaux, 89(11), 1996, pp. 1485-1490
Citation: S. Gandrille et al., A RAPID SCREENING METHOD FOR THE FACTOR-V ARG506-]GLN MUTATION, Blood coagulation & fibrinolysis, 6(3), 1995, pp. 245-248
Authors:
ALHENCGELAS M
EMMERICH J
GANDRILLE S
AUBRY ML
BENAILY N
FIESSINGER JN
AIACH M
Citation: M. Alhencgelas et al., PROTEIN-C INFUSION IN A PATIENT WITH INHERITED PROTEIN-C DEFICIENCY CAUSED BY 2 MISSENSE MUTATIONS - ARG 178 TO GLN AND ARG-1 TO HIS, Blood coagulation & fibrinolysis, 6(1), 1995, pp. 35-41
Authors:
BACHELOT C
SAFFROY R
GANDRILLE S
AIACH M
RENDU F
Citation: C. Bachelot et al., ROLE OF FC-GAMMA-RIIA GENE POLYMORPHISM IN HUMAN PLATELET ACTIVATION BY MONOCLONAL-ANTIBODIES, Thrombosis and haemostasis, 74(6), 1995, pp. 1557-1563
Citation: M. Aiach et al., A REVIEW OF MUTATIONS CAUSING DEFICIENCIES OF ANTITHROMBIN, PROTEIN-CAND PROTEIN-S, Thrombosis and haemostasis, 74(1), 1995, pp. 81-89
Authors:
GAUSSEM P
PICARD V
CHADEUF G
ARNAUD E
AIACH M
Citation: P. Gaussem et al., HUMAN THROMBIN VARIABLE REGION-1 INCLUDING E39 IS INVOLVED IN THE INTERACTIONS WITH R358 ALPHA-1-ANTITRYPSIN AND PROTEIN-C, Thrombosis and haemostasis, 73(6), 1995, pp. 929-929
Authors:
BACHELOR C
SAFFROY R
GANDRILLE S
AIACH M
RENDU F
Citation: C. Bachelor et al., ACTIVATION OF HUMAN PLATELETS BY MONOCLONAL-ANTIBODY IS DEPENDENT ON FC-GAMMA-RIIA POLYMORPHISM, Thrombosis and haemostasis, 73(6), 1995, pp. 1063-1063
Citation: V. Picard et al., IMPORTANCE OF THE P16-P13 REGION FOR ANTITHROMBIN-III INHIBITOR FUNCTION, Thrombosis and haemostasis, 73(6), 1995, pp. 1252-1252